Evidence map›Paper›PMID 38113241›Full record

ArticlePLOS global public health2023

Public perceptions of Ebola vaccines and confidence in health services to treat Ebola, malaria, and tuberculosis: Findings from a cross-sectional household survey in Uganda, 2020.

Aybüke Koyuncu, Rosalind J Carter, Joseph Musaazi, Apophia Namageyo-Funa, Victoria M Carter, Mohammed Lamorde, Dimitri Prybylski, Rose Apondi, Tabley Bakyaita, Amy L Boore and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Aybüke KoyuncuCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-3060-6279
Rosalind J CarterNational Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0003-2917-5827
Joseph MusaaziInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Apophia Namageyo-FunaCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Victoria M CarterCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mohammed LamordeInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Dimitri PrybylskiCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rose ApondiCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Tabley BakyaitaUganda Ministry of Health, Kampala, Uganda.
Amy L BooreCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jaco HomsyCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Vance R BrownCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Joanita KigoziInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Maria Sarah NabaggalaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Vivian NakateInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Emmanuel NkurunzizaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Daniel F StowellCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Richard WalwemaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Apollo OlowoInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Mohamed F JallohCenter for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Centers for Disease Control and Prevention · UGInfectious Diseases Institute · UGMinistry of Health · UGNational Center for Immunization and Respiratory Diseases · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uganda used Ebola vaccines as part of its preparedness and response during the 2018-2020 10th Ebola virus disease (EVD) outbreak in neighboring Democratic Republic of the Congo (DRC). We evaluated the public's perceptions of Ebola vaccines and compared their confidence in health services to treat Ebola versus malaria and tuberculosis as part of a survey on Ebola knowledge, attitudes, and practices (KAP) conducted in March 2020. A cross-sectional household survey was implemented in six districts in Uganda using multi-stage cluster sampling to randomly select participants. The districts were purposively selected from districts classified by the government as at high- or low-risk for an EVD outbreak. We describe perceptions of Ebola vaccines and confidence in health services to treat Ebola, tuberculosis, and malaria. Modified Poisson regression modeling was used to identify the demographic correlates of these outcomes. Among 3,485 respondents, 18% were aware of Ebola vaccines. Of those, 92% agreed that the vaccines were needed to prevent Ebola. Participants aged 15-24 years were 4% more likely to perceive such need compared to those 60 years and older (adjusted prevalence ratio [aPR] 1.04, 95% confidence interval [CI] 1.0-1.08). The perceived need was 5% lower among participants with at least some secondary education compared to uneducated participants (aPR 0.95; 0.92-0.99). Overall, 81% of those aware of the vaccines believed that everyone or most people in their community would get vaccinated if offered, and 94% said they would likely get vaccinated if offered. Confidence in health services to treat Ebola was lower compared to treating malaria or tuberculosis (55% versus 93% and 77%, respectively). However, participants from the EVD high-risk districts were 22% more likely to be confident in health services to treat Ebola compared to those in low-risk districts (aPR: 1.22; 95% CI: 1.08, 1.38). Our findings suggest that intent to take an Ebola vaccine during an outbreak was strong, but more work needs to be done to increase public awareness of these vaccines. The public's high confidence in health services to treat other health threats, such as malaria and tuberculosis, offer building blocks for strengthening their confidence in health services to treat EVD in the event of an outbreak.

Identifiers

PMID38113241
PMCPMC10729951
OpenAlexW4389946146

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.